Data validity questioned, Lancet hydroxychloroquine invalid research article retracted

Guide: Although not rigorous trials, but including the United States National Institutes of Health and the World Health Organization led the trial, hydroxychloroquine randomized trials are still in progressa research paper on the ineffectiveness of the treatment of patientsChinese with the new crown was withdrawn from the Lancet medical journal on Thursday after doctors and scientists questioned the validity of the data,reportedprevious study concluded that patients taking the antimalarial drug hydroxychloroquine had a higher risk of death than those who did not, leading some researchers to suspend clinical trialsthe three authors of the study, led by Mandyp Mehra of Harvard Medical School, and published in late MayBut they withdrew the study from The Lancet because independent peer reviewers could not access the data used for analysis"We all participated in this collaboration and contributed in good faith at this extraordinary time of the New Crown pandemic,"wrote in a statement on June 4"We apologize to you, editors and journal readers for any embarrassment or inconvenience this may causeThe study used data from more than 96,000 new crown patients in 671 hospitals on six continents, according toHowever, the company told peer reviewers that it would not disclose the complete data set for research because it would violate customer agreements and confidentiality requirementsSurgisphere Corporation is one of the study's co-authors, Sapan DesaiDesai did not sign the withdrawal application with three other co-authors, the report saidThe Lancet wrote in a statement that it "takes the issue of scientific integrity very seriously" and that "there are many outstanding issues regarding Surgisphere and the data allegedly included in this study."earlier, After a driver of President Donald Trump tested positive for a new crown, MrTrump underwent a two-week course of hydroxychloroquineBut another previously published study showed that the drug was not effective in preventing new crowns Another study of 368 patients, published in the New England Journal of Medicine in April , found that two main outcomes were death or critical illness in patients treated with hydroxychloroquine , although not rigorous, includes trials led by the National Institutes of Health and the World Health Organization, and randomized trials of hydroxychloroquine are still ongoing